QHSLab reports 30K+ digital assessments YTD, over $1M revenue for 9 months

QHSLab, Inc.

Over 30,000 patient digital medicine assessments in first 9 months of 2023; 800 initiated allergen immunotherapy.
Unaudited revenue for nine months ended Sep 30, 2023 exceeded $1 million with growing gross margins.
Physician client reimbursements increased 20-30% from adopting QHSLab digital health services.
ISP service line forecast to double daily output by year-end 2023; 2024 assessment run rate expected >65,000.
Platform added multi-language support, EHR matching, and automated patient self-management tools.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.